JUN 16, 2020 10:06 AM PDT

Wearable patch for melanoma patients

Research published in the journal ACS Nano describes a wearable patch that can be used to lessen side effects from chemotherapy and radiotherapy for melanoma patients. The innovation was created by researchers at Purdue University in response to the suffering that melanoma patients undergo when receiving conventional therapies to fight the cancer. 

Melanoma is an aggressive kind of skin cancer that can metastasize quickly if it is not treated early. Additionally, it is a particularly tricky cancer because melanoma cells are known for being recurrent in their nature.

"We developed a novel wearable patch with fully miniaturized needles, enabling unobtrusive drug delivery through the skin for the management of skin cancers," said Chi Hwan Lee, who is a Purdue assistant professor of biomedical engineering and mechanical engineering. "Uniquely, this patch is fully dissolvable by body fluids in a programmable manner such that the patch substrate is dissolved within one minute after the introduction of needles into the skin, followed by the gradual dissolution of the silicon needles inside the tissues within several months."

The bioresorbable silicon nanoneedles are constructed on a thin, flexible and water-soluble medical film which is used to insert the needles. The silicon nanoneedles dissolve quickly into the skin afterward but because they stay active over time, the patch provides delivery of anti-cancer drugs for  an extended period. Eventually, the biocompatible nanoneedles dissolve in into tissue fluids and reabsorb into the body without any adverse secondary effects. 

"The uniqueness of our technology arises from the fact that we used extremely small but long-lasting silicon nanoneedles with sharpened angular tips that are easy for their penetration into the skin in a painless and minimally invasive manner," Lee said.

The patch will provide more comfort to melanoma patients than conventional treatment options. Photo: Pixabay

Compared to conventional microneedles, the nanoneedles’ pore surface areas are able to provide a large drug loading capacity, which Lee says can target melanoma sites to deliver chemotherapeutic drugs. 

Following Eureka Alert, Lee said he got inspired to create such an innovation after observing how scared his daughter was of needles when receiving vaccinations.

Sources: ACS Nano, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 12, 2021
Cancer
Promising Drug Target Identified for Deadly Ovarian Cancer
AUG 12, 2021
Promising Drug Target Identified for Deadly Ovarian Cancer
Scientists at the University of Alabama at Birmingham have identified a gene called DOT1L for its role in progressing th ...
OCT 26, 2021
Immunology
Two Different Arms, Twice the Cancer-Killing Potential?
OCT 26, 2021
Two Different Arms, Twice the Cancer-Killing Potential?
Our immune system has developed an arsenal of sophisticated molecular weapons to defend us against the continuous barrag ...
OCT 28, 2021
Cancer
NF-κB: a Trick or a Treat for Cancer?
OCT 28, 2021
NF-κB: a Trick or a Treat for Cancer?
A family of proteins, known as transcription factors, regulate the biological process of converting DNA into RNA. T ...
NOV 10, 2021
Cannabis Sciences
Does Cannabis Use Reduce the Risk of Cancer?
NOV 10, 2021
Does Cannabis Use Reduce the Risk of Cancer?
In medical terminology, there are few terms as imposing as ‘cancer.’ According to the Centers for Disea ...
NOV 17, 2021
Cancer
Turkey, Tryptophan, and Cancer
NOV 17, 2021
Turkey, Tryptophan, and Cancer
As many people start to plan their Thanksgiving dinners, there will inevitably be a lot of talk about the turkey.  ...
NOV 29, 2021
Microbiology
How the Hepatitis B Virus Promotes Liver Cancer Development
NOV 29, 2021
How the Hepatitis B Virus Promotes Liver Cancer Development
It's estimated that about 240 million people worldwide have an HBV infection. Hepatitis B infections are linked to t ...
Loading Comments...